Literature DB >> 1008539

Effects of antibiotics on metabolism of peptidoglycan, protein, and lipids in Bifidobacterium bifidum subsp. pennsylvanicus.

G C Molenkamp, J H Veerkamp.   

Abstract

The formation of cell envelope components of Bifidobacterium bifidum subsp. pennsylvanicus was studied by measuring the incorporation of [(3)H]glycine, (14)C-labeled fatty acids, and N-benzoyl-[(14)C]glucosamine into the membrane protein, membrane lipids, and cell wall peptidoglycan, respectively. Inhibition of peptidoglycan synthesis by antibiotics (penicillin G, vancomycin, d-cycloserine, and bacitracin) and by the omission of glucosamine-containing growth factors caused a marked decrease in glycine incorporation into cellular as well as membrane protein, which was accompanied by a considerable enhancement of fatty acid incorporation. The uncoupling of protein and lipid synthesis led to the release of marked amounts of lipids from the cell under these conditions. Arrestment of protein synthesis by antibiotics (chloramphenicol, tetracycline, and actinomycin D) decreased peptidoglycan and lipid synthesis only partially, but did not lead to lipid release. Mg(2+) deficiency of the medium caused about 60% inhibition of growth and lipid synthesis, but protein synthesis and especially peptidoglycan synthesis were much less inhibited. Staphylococcin 1580 arrested the growth and also the synthesis of protein and peptidoglycan. However, the synthesis and turnover of lipids were considerably increased and a release of large amounts of lipids was observed. Peptidoglycan and cellular protein did not show any turnover either during normal growth or after the inhibition of cell wall and protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008539      PMCID: PMC429838          DOI: 10.1128/AAC.10.5.786

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  62 in total

1.  Stability of Escherichia coli membrane proteins during chloramphenicol treatment.

Authors:  A N Bacchus; G T Javor
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  Phospholipids of Escherichia coli in magnesium deficiency.

Authors:  T Günther; L Richter; J Schmalbeck
Journal:  J Gen Microbiol       Date:  1975-01

3.  Membrane protein synthesis in Micrococcus lysodeikticus and selective effect of chloramphenicol.

Authors:  C G Mendoza; M N Ledieu
Journal:  Can J Biochem       Date:  1975-05

4.  Effect of inhibition of deoxyribonucleic acid and protein synthesis on the direction of cell wall growth in Streptococcus faecalis.

Authors:  M L Higgins; L Daneo-Moore; D Boothby; G D Shockman
Journal:  J Bacteriol       Date:  1974-05       Impact factor: 3.490

5.  Thickened cell walls of Bacillus cereus grown in the presence of chloramphenicol: their fate during cell growth.

Authors:  K L Chung
Journal:  Can J Microbiol       Date:  1971-12       Impact factor: 2.419

6.  Morphokinetic reaction of cells of Streptococcus faecalis (ATCC 9790) to specific inhibition of macromolecular synthesis: dependence of mesosome growth on deoxyribonucleic acid synthesis.

Authors:  M L Higgins; L Daneo-Moore
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

7.  Determination of cell shape in bacteria.

Authors:  U L Henning
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

8.  Effects of colicin A and staphylococcin 1580 on amino acid uptake into membrane vesicles of Escherichia coli and staphylococcus aureus.

Authors:  A M Jetten; G D Vogels
Journal:  Biochim Biophys Acta       Date:  1973-07-18

9.  Biochemical changes in Bifidobacterium bifidum var. pennsylvanicus after cell wall inhibition. VIII. Composition and metabolism of phospholipids at different stages and conditions of growth.

Authors:  F W Van Schaik; J H Veerkamp
Journal:  Biochim Biophys Acta       Date:  1975-05-22

10.  Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.

Authors:  I Okawa; B Maruo; M Kageyama
Journal:  J Biochem       Date:  1975-07       Impact factor: 3.387

View more
  8 in total

Review 1.  Group B Streptococcus, phospholipids and pulmonary hypertension.

Authors:  J Curtis; G Kim; N B Wehr; R L Levine
Journal:  J Perinatol       Date:  2011-04       Impact factor: 2.521

2.  Biochemical and ultrastructural changes in Staphylococcus aureus treated with staphylococcin 1580.

Authors:  A Weerkamp; U T Heinen-von Borries; G D Vogels
Journal:  Antonie Van Leeuwenhoek       Date:  1978       Impact factor: 2.271

3.  The Bacillus subtilis cannibalism toxin SDP collapses the proton motive force and induces autolysis.

Authors:  Anne Lamsa; Wei-Ting Liu; Pieter C Dorrestein; Kit Pogliano
Journal:  Mol Microbiol       Date:  2012-04-02       Impact factor: 3.501

4.  Effects of growth conditions on the ion composition of Bifidobacterium bifidum subsp. pennsylvanicum.

Authors:  J H Veerkamp
Journal:  Antonie Van Leeuwenhoek       Date:  1977       Impact factor: 2.271

5.  The effect of penicillin on fatty acid synthesis and excretion in Streptococcus mutans BHT.

Authors:  J L Brissette; R A Pieringer
Journal:  Lipids       Date:  1985-03       Impact factor: 1.880

6.  Phosphatidylglycerol as biosynthetic precursor for the poly(glycerol phosphate) backbone of bifidobacterial lipoteichoic acid.

Authors:  H J Op den Camp; A Oosterhof; J H Veerkamp
Journal:  Biochem J       Date:  1985-06-15       Impact factor: 3.857

Review 7.  A How-To Guide for Mode of Action Analysis of Antimicrobial Peptides.

Authors:  Ann-Britt Schäfer; Michaela Wenzel
Journal:  Front Cell Infect Microbiol       Date:  2020-10-19       Impact factor: 5.293

8.  Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota.

Authors:  Federica Del Chierico; Valentina Trapani; Valentina Petito; Sofia Reddel; Giuseppe Pietropaolo; Cristina Graziani; Letizia Masi; Antonio Gasbarrini; Lorenza Putignani; Franco Scaldaferri; Federica I Wolf
Journal:  Nutrients       Date:  2021-11-23       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.